For the uses of DEHP, BBP, DBP and DIBP that will no longer be exempted from the authorisation requirement, it is appropriate to indicate the dates referred to in point (i) of Article 58(1)(c) of Regulation (EC) No 1907/2006, taking into account the Agency’s recommendation of 10 July 2019 and its capacity to handle applications for authorisations. As regards uses of DEHP in medical devices, the dates should also take into account the transitional provisions for the application of Regulations (EU) 2017/745 [Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (OJ L 117, 5.5.2017, p. 1).] and (EU) 2017/746 [Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU (OJ L 117, 5.5.2017, p. 176).] of the European Parliament and of the Council.
Recital 6, Regulation (EU) 2021/2045
In forcesince 23 Nov 2021
Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 Decembe…58Law
Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January…Law
Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 Novembe…Law
- celex=31990L0385
- celex=31998L0079
- num:eu=1990/385
- num:eu=1993/42